Medical Research Wiki

UC/Proctitis Research Map

Properties1
tagsulcerative-colitis, ulcerative-proctitis, causes, mechanisms, cure-research

9 min read

UC/Proctitis Research Map

This page organizes research questions and mechanisms for Paul’s UC/proctitis cure/remedy investigation.

Root-cause buckets to investigate

  • Central evolving model: Proctitis.
  • Barrier integrity and mucus layer failure.
  • Rectal/distal-colon microbiome differences.
  • Constipation, stool retention, and local irritant contact time.
  • Hydrogen sulfide, sulfur metabolism, bile acids, ammonia, phenols, and other microbial metabolites.
  • Redox/oxidative stress theories, including Dr. Pravda/RDLA/STS-related material.
  • Gut permeability/endotoxin/LPS and systemic inflammation.
  • Immune dysregulation vs infection/pathobiont vs environmental trigger models.
  • Stress/autonomic/vagal/HPA-axis modulation.
  • Sleep apnea/sleep deprivation as inflammatory amplifier.
  • Food-trigger mechanisms: dairy, gluten/wheat, high sulfur, processed foods, emulsifiers; for dairy, distinguish milk-protein allergy/hypersensitivity, oral-tolerance failure, lactose, fat/bile, additives, and dairy-triggered UC amplification.
  • Liver-bile-lipid axis: cholesterol and ALP correlations.
  • Genetic susceptibility and epigenetic/environmental activation.

Priority mechanistic questions

Why distal first?

Paul’s proctitis focus makes this a central question. Investigate:

  • local microbiome and metabolite gradients along the colon;
  • rectal mucus layer and epithelial vulnerability;
  • fecal stasis/constipation/contact time;
  • local immune cell populations;
  • vascular/lymphatic differences;
  • mechanical irritation and pelvic floor factors;
  • bile acid/metabolite concentration near distal stool;
  • rectal reservoir physiology.

Why mucus before blood?

Hypotheses:

  • mucus secretion as early protective response;
  • goblet cell stress/depletion;
  • mild distal barrier irritation before ulceration;
  • dysbiosis/metabolite changes;
  • constipation-induced mucosal friction/retention.

Why cholesterol and ALP track flares?

Hypotheses:

  • inflammatory lipid remodeling;
  • endotoxin/LPS effect on hepatic cholesterol synthesis/clearance;
  • bile flow/liver-gut axis involvement;
  • ALP as intestinal/liver/bone signal;
  • PSC-adjacent screening consideration in IBD context;
  • diet/fasting/weight/thyroid/sleep confounding.

Source digestion priorities

Use source-digestion-queue and process in this order:

  1. Clinical/mechanistic papers.
  2. Coach/clinician/protocol pages.
  3. YouTube videos and comments.
  4. Social/anecdotal sources.
  5. Books/podcasts/media.
  6. Other web sources.
  7. Internal/generated notes.

Promotion targets

When a source is digested, promote it into one or more:

2026-06-17 — Causal mechanism digest 001

Journal note: UC Causal Mechanism Digest 001 — Barrier, Mucus PC, Redox, ALP, Coconut Water

Promoted causal updates:

  • Mucus phosphatidylcholine/barrier failure is now a priority causal branch.
  • Colonocyte energy/redox dysfunction is now a priority causal branch, especially mitochondrial thiolase/butyrate oxidation/hydrogen peroxide.
  • Microbial niche/pathobiont positioning is now a priority branch, especially organisms/metabolism at the mucus layer.
  • Distal/proctitis onset may be explained by local mucus PC reserve, stool contact time, microbial metabolite exposure, and rectal vulnerability.
  • ALP/cholesterol flare tracking should be treated as a gut-liver-lipid axis research branch, not a side note.

New research tasks:

2026-06-17 — Causal mechanism digest 002

Journal note: Proctitis First

Canonical mechanism page: Proctitis-First Onset Mechanism in UC

Promoted causal updates:

  • UC’s rectal/proctitis-first pattern is now treated as a core mechanism to explain, not a descriptive side fact.
  • Active UC mucus penetrability and bacterial epithelial contact are central evidence for the barrier-threshold model.
  • Mucus phosphatidylcholine thinning toward the rectum is now the strongest candidate explanation for lowest distal barrier reserve.
  • Rectal/cecal stasis and prolonged mucosal contact support Paul’s constipation/contact-time and cecal-pain observations.
  • Diversion colitis/SCFA data clarify that the fecal stream is a dual-edged context: it supplies needed fuels but can damage weak barrier if microbes/metabolites/contact time become unfavorable.

2026-06-17 — Causal mechanism digest 003

Journal note: UC Causal Mechanism Digest 003 — Dairy, Milk Protein, Gluten, and Wheat Triggers

Canonical mechanism page: Wheat Food-Trigger Mechanisms in UC

Promoted causal updates:

  • Dairy/gluten/wheat are now modeled as personal trigger/amplifier nodes, not universal UC root causes.
  • Paul’s dairy → blood signal remains high-priority despite mixed population-level dairy evidence.
  • Dairy mechanism branches to track: milk protein/casein/whey immune reactivity, lactose/FODMAP fermentation, A1/A2 beta-casein, fat/bile/microbiome, histamine/mast-cell/local mucosal response.
  • Gluten/wheat mechanism branches to track: celiac disease, non-celiac gluten sensitivity, non-celiac wheat sensitivity, fructans/FODMAPs, amylase-trypsin inhibitors, wheat processing/additives.
  • Future personal tracking should distinguish symptom relief from objective inflammatory control.

2026-06-28 — Milk allergy / oral tolerance digest

Journal note: Non-IgE Dairy Hypersensitivity Digest

Canonical mechanism page: Non-IgE Dairy Hypersensitivity in UC

Promoted causal updates:

  • Dairy is best framed as a personal trigger/amplifier branch in Paul, not as proof that milk allergy universally causes UC.
  • Older milk/UC literature made cow milk suspicious for a subset, but later milk-protein antibody and food-specific IgE studies argue against universal milk-allergy causation.
  • The refined hypothesis is milk-triggered loss-of-tolerance / barrier-threshold amplification in a vulnerable distal gut.
  • Key mechanism distinctions: IgE-mediated allergy, non-IgE milk-protein hypersensitivity, eosinophilic/mast-cell GI overlap, lactose malabsorption, and dairy-triggered UC flare without true allergy.
  • Useful next evidence would be component-specific tracking, biopsy review for eosinophils/mast cells, allergy/lactose testing if clinically appropriate, and calprotectin/symptom tracking across dairy-free blocks.

2026-06-17 — Causal mechanism digest 004

Journal note: UC Causal Mechanism Digest 004 — Sleep Apnea, Poor Sleep, Hypoxia, and Circadian Disruption

Canonical mechanism page: Circadian Disruption as UC Barrier Amplifiers

Promoted causal updates:

  • Sleep/apnea/circadian disruption is now modeled as a barrier-reserve and inflammatory-threshold controller.
  • Poor sleep has direct UC relapse signal: 34.5% vs 10.3% in the 2025 prospective observational study.
  • Circadian disruption connects directly to core mechanisms: intestinal permeability, calprotectin, TNF-α, dysbiosis, and SCFA/butyrate-associated taxa.
  • OSA is more prevalent in IBD/UC cohorts and belongs in Paul’s symptom/lab tracking model.
  • Melatonin/circadian interventions are indexed as clinician-discussion research leads, not recommendations.

2026-06-18 — Causal mechanism digest 005

Journal note: UC Causal Mechanism Digest 005 — ALP, Cholesterol, Gut-Liver-Lipid Axis

Canonical mechanism page: Gut-Liver-Lipid Axis in UC

Promoted causal updates:

  • ALP/cholesterol are now an objective biomarker branch of the central theory.
  • Serum ALP must be interpreted by source/fraction: liver/bile duct vs bone vs intestinal vs mixed.
  • PSC is a clinician-guided screening question in persistent cholestatic labs, not an assumption from ALP alone.
  • Intestinal alkaline phosphatase links ALP biology to LPS detoxification, barrier integrity, and microbiome regulation.
  • Paul’s cholesterol-rise-with-flare pattern contradicts the common population pattern of lower lipids with active IBD, making it a personal-outlier clue to track carefully.

2026-06-18 — Causal mechanism digest 006

Journal note: UC Causal Mechanism Digest 006 — Mucus Phosphatidylcholine and Delayed-Release PC

Canonical mechanism/intervention page: Delayed-Release PC Barrier Repair in UC

Promoted causal updates:

  • Mucus phosphatidylcholine remains a core barrier-repair and proctitis-first hypothesis.
  • Early delayed-release PC RCT/meta-analysis evidence is hopeful, but research-line concentrated.
  • 2024 multicenter LT-02 induction trials failed the primary endpoint, so the clinical intervention evidence is mixed.
  • Generic lecithin/systemic PC is not equivalent to studied colon-targeted delayed/modified-release PC.
  • PC species/metabolism, including PC34:1, PEMT, and PCYT1α, may matter.

2026-06-18 — Causal mechanism digest 007

Journal note: UC Causal Mechanism Digest 007 — Redox, Butyrate Oxidation, Roediger, and Pravda

Canonical mechanism page: Thiolase Branch in UC

Promoted causal updates:

  • Colonocyte energy/redox dysfunction is now a root-cause-grade mechanistic branch.
  • Santhanam 2007 anchors the branch with UC-specific thiolase impairment, increased H2O2, and redox reversibility ex vivo.
  • Pravda/Roediger overlap is useful, but protocol/cure claims remain evidence-graded and safety-filtered.
  • H2S/sulfur is modeled as dose/context dependent, not universally bad.
  • High-risk redox-adjacent claims such as hydrogen peroxide enemas and chlorine dioxide/CDS/MMS are explicitly safety-flagged.

2026-06-18 — Causal mechanism digest 008

Journal note: UC Causal Mechanism Digest 008 — Constipation, Contact Time, Pelvic Floor, and Local Rectal Mechanics

Canonical mechanism page: Pelvic Floor Mechanics in UC Proctitis

Promoted causal updates:

  • UC-associated constipation/contact-time is now a core personal-pattern branch, not a side symptom.
  • UCAC can occur in active disease, distal disease, and remission; it can mimic refractory inflammation.
  • James 2018 found 46% of one UC cohort met proximal-constipation definition, with active and left-sided disease associations.
  • Pelvic-floor/gut-directed behavioral treatment is an actionable clinician question for incomplete evacuation/constipation in selected IBD patients.
  • Local rectal therapy evidence reinforces rectal-local thinking for proctitis.

2026-06-18 — Causal mechanism digest 009

Journal note: UC Causal Mechanism Digest 009 — Pathobionts, Mucus-Layer Ecology, and Microbial Positioning

Canonical mechanism page: Microbial Positioning in UC

Promoted causal updates:

  • Microbial location/virulence-factor logic is now a core branch: stool microbiome labels are less important than whether microbes/toxins reach inner mucus, epithelium, crypts, or tissue.
  • Johansson mucus-layer work remains a top mechanistic anchor: healthy inner MUC2 mucus excludes bacteria; active UC mucus becomes penetrable.
  • Aeromonas/aerolysin is an emerging high-signal subgroup candidate but not yet clinically actionable.
  • Fusobacterium and oral-gut pathobionts remain plausible amplifiers, not proven universal causes.
  • Akkermansia/R. gnavus/SRB examples reinforce strain/context/metabolite nuance.

2026-06-18 — Causal mechanism digest 010

Journal note: UC Causal Mechanism Digest 010 — Beneficial Commensals, Probiotics, Prebiotics, Butyrate, and Fiber

Canonical mechanism/intervention page: Butyrate Ecology in UC

Promoted causal updates:

  • Beneficial commensal/butyrate ecology is now a core counterpart to the pathobiont/toxin branch.
  • F. prausnitzii and Roseburia hominis are the priority beneficial-butyrate organisms to track.
  • EcN has unusually strong strain-specific UC maintenance evidence; De Simone/VSL#3-style products have active-UC signals with product-identity caveats.
  • Psyllium/Plantago bridges constipation management and butyrate ecology, but fiber tolerance/contact-time risk is central for Paul.
  • Direct butyrate delivery remains mechanistically attractive but clinically mixed.

2026-06-19 — Causal mechanism digest 011

Journal note: UC Causal Mechanism Digest 011 — Constipation-Safe Prebiotics, Fiber, Food Methods, and Full Evacuation

Canonical mechanism/intervention page: Full-Evacuation Strategy in UC Proctitis

Promoted causal updates:

  • Constipation interventions should be judged by contact-time reduction, not generic fiber intake.
  • Kiwi is a promising first-pass whole-food constipation candidate because kiwi/prunes/psyllium improved chronic constipation and kiwi had the lowest adverse-event/dissatisfaction signal.
  • Psyllium remains the strongest fiber candidate but must be weighed against gas/retention/UCAC worsening.
  • PHGG, resistant starch, and 4-SURE-style fermentation strategies remain promising but caveated.
  • Footstool/posture and pelvic-floor/outlet evaluation are core low-systemic-exposure strategies for incomplete evacuation.

Scite validation pass — 2026-06-27

See UC Central Theory Scite Validation Pass. Scite access is working and confirmed the main central-theory branches while adding several refinements:

  • MUC2 mucus-barrier and active UC penetrability are strongly supported.
  • UCAC/contact-time and sleep/circadian remain high-value Paul-specific branches.
  • 4-SURE-style functional microenvironment targeting strengthened the sulfur/H₂S/protein-fermentation branch.
  • IAP/SRB/Snail biology may link ALP/IAP, sulfate-reducing bacteria, LPS, and tight junctions, but remains research-grade.
  • Lipid evidence supports interpreting Paul’s cholesterol pattern as a downstream biomarker clue unless proven otherwise.

2026-06-29 — Scite-heavy functional distal microenvironment pass

Journal note: UC Functional Distal Microenvironment — Scite-Heavy Research Pass

Canonical mechanism page: Functional Distal Microenvironment in UC Proctitis

Promoted causal updates:

  • The active research target is now framed as a functional rectal/distal environment rather than a generic stool microbiome.
  • 4-SURE functional profiling directly measured reduced H₂S production and indole after a diet intervention.
  • Diet interpretation must keep protein, sulfur amino acids, fiber/resistant starch, fat/bile context, additives, and contact time together.
  • F. prausnitzii/Roseburia remain the beneficial-butyrate counterweight to pathobiont/H₂S/protein-fermentation pressure.
  • UCAC/contact-time is a gating variable for whether fiber/prebiotic/resistant-starch strategies help or backfire.

Graph View

Backlinks